CVS Health settles DOJ opioid case for USD 315 million
Alpha Vantage · AD HOC NEWS · · AI-summarised by FinFlash
CVS Health settled a USD 315 million case with the U.S. Department of Justice over allegations of unlawful opioid prescriptions, agreeing to enhanced monitoring and reporting. The company kept its fiscal 2026 adjusted EPS guidance and posted 7.30 percent year-over-year revenue growth in the second quarter. It declared a USD 0.665 quarterly dividend.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.